Apimeds, Inc.
🇰🇷South Korea
Evaluate Safety and Efficacy of Apitox Add-on Therapy for Improving Disability and Quality of Life in MS Patients
Phase 3
- Conditions
- Multiple Sclerosis
- Interventions
- Drug: Apitox - pure honeybee toxinDrug: Placebo
- First Posted Date
- 2018-10-18
- Last Posted Date
- 2018-10-18
- Lead Sponsor
- Apimeds, Inc.
- Target Recruit Count
- 468
- Registration Number
- NCT03710655
Apitox, Honeybee Toxin for Pain and Inflammation of Osteoarthritis
Phase 3
Completed
- Conditions
- Osteoarthritis of the Knee
- Interventions
- Biological: histamineBiological: Apitox, purified honeybee toxin, lyophilized in saline
- First Posted Date
- 2010-04-28
- Last Posted Date
- 2016-12-13
- Lead Sponsor
- Apimeds, Inc.
- Target Recruit Count
- 363
- Registration Number
- NCT01112722
- Locations
- 🇺🇸
Functional Research LLC, Gulf Shores, Alabama, United States
🇺🇸SC Clinical Research Inc., Upland, California, United States
🇺🇸Axis Clinical Trials, Los Angeles, California, United States
Apitox, Honeybee Venom Treatment for Osteoarthritis Pain and Inflammation
Phase 2
Completed
- Conditions
- Osteoarthritis of the Knee
- Interventions
- Drug: honeybee venom (Apitoxin (Korea) Apitox (USA))
- First Posted Date
- 2009-07-30
- Last Posted Date
- 2010-05-05
- Lead Sponsor
- Apimeds, Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT00949754
- Locations
- 🇺🇸
Radiant Research - Columbus, Columbus, Ohio, United States
🇺🇸Radiant Research Inc., Pinellas Park, Florida, United States
🇺🇸Radiant Research - Chicago, Chicago, Illinois, United States
© Copyright 2025. All Rights Reserved by MedPath